(Q46797892)

25 December 2017

title

Second hepatic resection for recurrent hepatocellular carcinoma in patients with chronic hepatitis C. (English)

1 reference

25 December 2017

recurrent hepatocellular carcinoma

main subject

1 reference

Shoji Kubo

1

1 reference

25 December 2017

Shigekazu Takemura

2

1 reference

25 December 2017

Takahiro Uenishi

3

1 reference

25 December 2017

Takatsugu Yamamoto

4

1 reference

25 December 2017

Kazuki Ohba

5

1 reference

25 December 2017

Masao Ogawa

6

1 reference

25 December 2017

Seikan Hai

7

1 reference

25 December 2017

Tsuyoshi Ichikawa

8

1 reference

25 December 2017

Shintaro Kodai

9

1 reference

25 December 2017

Hiroji Shinkawa

10

1 reference

25 December 2017

Hiromu Tanaka

11

1 reference

25 December 2017

publication date

1 April 2008

1 reference

25 December 2017

published in

World Journal of Surgery

1 reference

25 December 2017

volume

32

1 reference

25 December 2017

issue

4

1 reference

25 December 2017

page(s)

632-638

1 reference

25 December 2017

Effects of continuous hepatitis with persistent hepatitis C viremia on outcome after resection of hepatocellular carcinoma.

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00268-007-9365-Z

Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-007-9365-Z

Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-007-9365-Z

Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-007-9365-Z

Influence of previous interferon therapy on recurrence after resection of hepatitis c virus-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-007-9365-Z

Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies

21 January 2018

1 reference

12 December 2020

Risk factors for recurrence after resection of hepatitis C virus-related hepatocellular carcinoma

1 reference

12 December 2020

Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C. Osaka Hepatocellular Carcinoma Prevention Study Group

1 reference

12 December 2020

Effect of interferon-alpha on progression of cirrhosis to hepatocellular carcinoma: a retrospective cohort study. International Interferon-alpha Hepatocellular Carcinoma Study Group

1 reference

12 December 2020

Patterns of and risk factors for recurrence after liver resection for well-differentiated hepatocellular carcinoma: a special reference to multicentric carcinogenesis after operation

1 reference

12 December 2020

Relationship between response to previous interferon therapy and postoperative recurrence of hepatitis C virus-related hepatocellular carcinoma

1 reference

12 December 2020

Relationship between the recurrence of hepatocellular carcinoma (HCC) and serum alanine aminotransferase levels in hepatectomized patients with hepatitis C virus-associated cirrhosis and HCC.

1 reference

12 December 2020

Clinical significance of hepatic resection in hepatocellular carcinoma: analysis by disease-free survival curves

1 reference

12 December 2020

Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.

1 reference

12 December 2020

Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis.

1 reference

12 December 2020

Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group

1 reference

12 December 2020

Prognostic factors after repeat hepatectomy for recurrent hepatocellular carcinoma.

1 reference

12 December 2020

Postoperative hepatitis status as a significant risk factor for recurrence in cirrhotic patients with small hepatocellular carcinoma

1 reference

12 December 2020

Selection Criteria for Repeat Hepatectomy in Patients With Recurrent Hepatocellular Carcinoma

1 reference

12 December 2020

Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor-A prospective randomized study of hepatitis C virus-related liver cancer

1 reference

12 December 2020

Therapeutic modalities in hepatitis C: challenges and development

1 reference

12 December 2020

Repeat liver resection for hepatocellular carcinoma

1 reference

12 December 2020

Surgical treatment for hepatocellular carcinoma detected after successful interferon therapy

1 reference

12 December 2020

Indications for, and effectiveness of, a second hepatic resection for recurrent hepatocellular carcinoma.

1 reference

12 December 2020

Classification of chronic hepatitis: diagnosis, grading and staging

1 reference

12 December 2020

Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment

1 reference

12 December 2020

Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma

1 reference

12 December 2020

Randomized clinical trial of long-term outcome after resection of hepatitis C virus-related hepatocellular carcinoma by postoperative interferon therapy

1 reference

12 December 2020

10.1007/S00268-007-9365-Z

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017